Travere Therapeutics, Inc. TVTX Interest Paid
Interest Paid at other companies
Other financials
Where this comes from
Reported directly by Travere Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestPaidNet.
The official record: Travere Therapeutics, Inc.’s 10-K, filed February 19, 2026, on SEC EDGAR. View the filing →
Ask your AI about Travere Therapeutics, Inc.'s interest paid.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Travere Therapeutics, Inc.'s interest paid?
- Travere Therapeutics, Inc. (TVTX) reported interest paid of $2.21M in Q4 2025.
- How has Travere Therapeutics, Inc.'s interest paid changed year-over-year?
- Travere Therapeutics, Inc.'s interest paid decreased by 0.0% year-over-year, from $2.21M to $2.21M.
- What is the long-term trend for Travere Therapeutics, Inc.'s interest paid?
- Over 4 years (2021 to 2025), Travere Therapeutics, Inc.'s interest paid has grown at a 4.8% compound annual growth rate (CAGR), from $7.33M to $8.84M.
- What does interest paid mean?
- Supplemental disclosure of total cash interest paid on all debt and lease obligations during the period.